SONO TEK CORP - Quarter Report: 2019 May (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended: May 31, 2019
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File No.: 0-16035
(Exact name of registrant as specified in its charter)
New York | 14-1568099 |
(State or other jurisdiction of | (IRS Employer |
incorporation or organization) | Identification No.) |
2012 Rt. 9W, Milton, NY 12547
(Address of Principal Executive Offices) (Zip Code)
Issuer's telephone no., including area code: (845) 795-2020
Securities Registered Pursuant to Section 12(b) of the Act: None
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
None | N/A | N/A |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☑| NO ☐
Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☑ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ☐ | Accelerated Filer ☐ |
Non-Accelerated Filer ☐ | Smaller reporting company ☑ |
Emerging Growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☑
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
Outstanding as of July 12, 2019 | |
Class | |
Common Stock, par value $.01 per share | 15,301,613 |
SONO-TEK CORPORATION
INDEX
Part I - Financial Information | Page |
Item 1 – Condensed Consolidated Financial Statements: | 1 - 3 |
Condensed Consolidated Balance Sheets – May 31, 2019 (Unaudited) and February 28, 2019 | 1 |
Condensed Consolidated Statements of Operations – Three Months Ended May 31, 2019 and 2018 (Unaudited) | 2 |
Condensed Consolidated Statements of Stockholders' Equity - Three Months Ended May 31, 2019 and 2018 (Unaudited) |
3 |
Condensed Consolidated Statements of Cash Flows – Three Months Ended May 31, 2019 and 2018 (Unaudited) | 4 |
Notes to Condensed Consolidated Financial Statements | 5 - 11 |
Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations | 12 –17 |
Item 3 – Quantitative and Qualitative Disclosures about Market Risk | 17 |
Item 4 – Controls and Procedures | 17 |
Part II - Other Information | 18 |
Signatures and Certifications | 19 |
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
May 31, 2019 | February 28, | |||||||
(Unaudited) | 2019 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 1,922,886 | $ | 3,144,123 | ||||
Marketable securities | 3,779,187 | 2,365,706 | ||||||
Accounts receivable (less allowance of $46,000) | 1,332,353 | 1,397,891 | ||||||
Inventories, net | 2,378,720 | 1,658,016 | ||||||
Prepaid expenses and other current assets | 105,013 | 395,005 | ||||||
Total current assets | 9,518,159 | 8,960,741 | ||||||
Land | 250,000 | 250,000 | ||||||
Buildings, net | 1,712,123 | 1,731,547 | ||||||
Equipment, furnishings and building improvements, net | 866,471 | 802,932 | ||||||
Intangible assets, net | 118,778 | 122,941 | ||||||
Deferred tax asset | 332,017 | 332,017 | ||||||
TOTAL ASSETS | $ | 12,797,548 | $ | 12,200,178 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 1,013,961 | $ | 585,694 | ||||
Accrued expenses | 614,518 | 632,706 | ||||||
Customer deposits | 1,334,306 | 1,149,558 | ||||||
Current portion of long term debt | 164,410 | 162,816 | ||||||
Income taxes payable | 12,575 | 6,272 | ||||||
Total current liabilities | 3,139,770 | 2,537,046 | ||||||
Deferred tax liability | 370,757 | 370,757 | ||||||
Long term debt, less current maturities | 665,838 | 707,715 | ||||||
Total liabilities | 4,176,365 | 3,615,518 | ||||||
Stockholders’ Equity | ||||||||
Common stock, $.01 par value; 25,000,000 shares authorized, 15,301,613 and 15,197,563 shares issued and outstanding, respectively | 153,016 | 151,976 | ||||||
Additional paid-in capital | 8,939,877 | 8,929,607 | ||||||
Accumulated deficit | (471,710 | ) | (496,923 | ) | ||||
Total stockholders’ equity | 8,621,183 | 8,584,660 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 12,797,548 | $ | 12,200,178 |
See notes to unaudited condensed consolidated financial statements.
1
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended May 31 | ||||||||
2019 | 2018 | |||||||
Net Sales | $ | 2,822,428 | $ | 2,700,860 | ||||
Cost of Goods Sold | 1,517,493 | 1,429,663 | ||||||
Gross Profit | 1,304,935 | 1,271,197 | ||||||
Operating Expenses | ||||||||
Research and product development costs | 337,173 | 333,866 | ||||||
Marketing and selling expenses | 677,412 | 629,788 | ||||||
General and administrative costs | 285,813 | 275,392 | ||||||
Total Operating Expenses | 1,300,398 | 1,239,046 | ||||||
Operating Income | 4,537 | 32,151 | ||||||
Interest Expense | (8,947 | ) | (10,614 | ) | ||||
Interest and Dividend Income | 31,171 | 34,606 | ||||||
Realized gain on sale of marketable securities | — | 29,392 | ||||||
Net unrealized loss on marketable securities | — | (49,061 | ) | |||||
Other income | 4,755 | 2,520 | ||||||
Income Before Income Taxes | 31,516 | 38,994 | ||||||
Income Tax Expense | 6,303 | 17,564 | ||||||
Net Income | $ | 25,213 | $ | 21,430 | ||||
Basic Earnings Per Share | $ | 0.00 | $ | 0.00 | ||||
Diluted Earnings Per Share | $ | 0.00 | $ | 0.00 | ||||
Weighted Average Shares - Basic | 15,268,071 | 14,987,613 | ||||||
Weighted Average Shares - Diluted | 15,357,295 | 15,088,512 |
See notes to unaudited condensed consolidated financial statements.
2
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
THREE MONTHS ENDED MAY 31, 2019 AND 2018
(Unaudited)
Common Stock Par Value $.01 | Additional Paid – In | Accumulated Other Comprehensive | Accumulated | Total Stockholders’ | ||||||||||||||||||||
Shares | Amount | Capital | Income (Loss) | Deficit | Equity | |||||||||||||||||||
Balance – February 28, 2018 | 14,986,367 | $ | 149,864 | $ | 8,901,171 | $ | 101,605 | $ | (760,115 | ) | $ | 8,392,525 | ||||||||||||
Reclassification of unrealized gain on marketable securities upon adoption of ASU 2016-01 | (101,605 | ) | 101,605 | — | ||||||||||||||||||||
Cashless exercise of stock options | 2,536 | 26 | (26 | ) | — | |||||||||||||||||||
Stock based compensation expense | 8,900 | 8,900 | ||||||||||||||||||||||
Net Income | 21,430 | 21,430 | ||||||||||||||||||||||
Balance – May 31, 2018 | 14,988,903 | $ | 149,890 | $ | 8,910,045 | $ | — | $ | (637,080 | ) | $ | 8,422,855 | ||||||||||||
Balance – February 28, 2019 | 15,197,563 | $ | 151,976 | $ | 8,929,607 | $ | — | $ | (496,923 | ) | $ | 8,584,660 | ||||||||||||
Stock based compensation expense | 11,310 | 11,310 | ||||||||||||||||||||||
Cashless exercise of stock options | 104,050 | 1,040 | (1,040 | ) | — | |||||||||||||||||||
Net Income | 25,213 | 25,213 | ||||||||||||||||||||||
Balance – May 31, 2019 | 15,301,613 | $ | 153,016 | $ | 8,939,877 | $ | — | $ | (471,710 | ) | $ | 8,621,183 |
See notes to unaudited condensed consolidated financial statements.
3
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended May 31, | ||||||||
2019 | 2018 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net Income | $ | 25,213 | $ | 21,430 | ||||
Adjustments to reconcile net income to net cash | ||||||||
provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 89,207 | 80,893 | ||||||
Stock based compensation expense | 11,310 | 8,900 | ||||||
Inventory reserve | 14,000 | 18,000 | ||||||
Unrealized loss on marketable securities | — | 49,061 | ||||||
Decrease (Increase) in: | ||||||||
Accounts receivable | 65,538 | (198,504 | ) | |||||
Inventories | (734,704 | ) | (89,372 | ) | ||||
Prepaid expenses and other current assets | 289,992 | 4,773 | ||||||
(Decrease) Increase in: | ||||||||
Accounts payable and accrued expenses | 410,079 | (290,133 | ) | |||||
Customer Deposits | 184,748 | 2,895 | ||||||
Income taxes payable | 6,303 | 17,564 | ||||||
Net Cash Provided By (Used In) Operating Activities | 361,686 | (374,493 | ) | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchase of equipment and furnishings | (129,159 | ) | (101,634 | ) | ||||
(Purchase) Sale of marketable securities | (1,413,481 | ) | 40,093 | |||||
Net Cash (Used In) Investing Activities | (1,542,640 | ) | (61,541 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Repayment of long-term debt | (40,283 | ) | (38,678 | ) | ||||
Net Cash (Used In) Financing Activities | (40,283 | ) | (38,678 | ) | ||||
NET (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,221,237 | ) | (474,712 | ) | ||||
CASH AND CASH EQUIVALENTS | ||||||||
Beginning of period | 3,144,123 | 2,016,464 | ||||||
End of period | $ | 1,922,886 | $ | 1,541,752 | ||||
SUPPLEMENTAL CASH FLOW DISCLOSURE: | ||||||||
Interest paid | $ | 8,947 | $ | 10,614 | ||||
Taxes Paid | $ | — | $ | — |
See notes to unaudited condensed consolidated financial statements.
4
SONO-TEK CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
THREE MONTHS ENDED MAY 31, 2019 and 2018
(Unaudited)
NOTE 1: BUSINESS DESCRIPTION
Sono-Tek Corporation (the “Company”, “Sono-Tek”, “We” or “Our”) was incorporated in New York on March 21, 1975. We are the world leader in the design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. We design and manufacture custom-engineered ultrasonic coating systems and also provide patented nozzles and generators for manufacturers’ equipment.
The accompanying unaudited condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Accordingly, the condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended February 28, 2019 (“fiscal year 2019”) contained in the Company’s 2019 Annual Report on Form 10-K filed with the SEC. The Company’s current fiscal year ends on February 29, 2020 (“fiscal 2020”).
NOTE 2: SIGNIFICANT ACCOUNTING POLICIES
Cash and Cash Equivalents - Cash and cash equivalents consist of money market mutual funds, short term commercial paper and short-term certificates of deposit with original maturities of 90 days or less.
Consolidation - The accompanying condensed consolidated financial statements of the Company, include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (“SIP”). SIP operates as a real estate holding company for the Company’s real estate operations.
Earnings Per Share - Basic earnings per share (“EPS”) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
Equipment, Furnishings and Leasehold Improvements – Equipment, furnishings and leasehold improvements are stated at cost. Depreciation of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which range from three to five years.
Fair Value of Financial Instruments - The Company follows the guidance in the “Fair Value Measurements and Disclosure Topic” of the Accounting Standards Codification for assets and liabilities measured at fair value on a recurring basis. This guidance establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, the guidance requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
Level 1: Quoted prices in active markets.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.
5
The fair values of financial assets of the Company were determined using the following categories at May 31, 2019 and February 28, 2019, respectively:
Quoted Prices in Active Markets | ||||||||
(Level 1) | ||||||||
May 31, 2019 | February 28, 2019 | |||||||
Marketable Securities | $ | 3,779,187 | $ | 2,365,706 |
Marketable Securities include mutual funds, certificates of deposit and US Treasury securities, totaling $3,779,187 and $2,365,706 as of May 31, 2019, and February 28, 2019, respectively, that are considered to be highly liquid and easily tradeable. These securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company’s marketable securities are considered to be available-for-sale investments as defined under ASC 320 “Investments – Debt and Equity Securities.”
Income Taxes - The Company accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized.
Intangible Assets -Include costs of patent applications which are deferred and charged to operations over seventeen years for domestic patents and twelve years for foreign patents. The accumulated amortization of patents is $163,127 and $160,433 at May 31, 2019 and February 28, 2019, respectively. Annual amortization expense of such intangible assets is expected to be approximately $11,000 per year for the next five years.
Interim Reporting - The attached summary condensed consolidated financial information does not include all disclosures required to be included in a complete set of financial statements prepared in conformity with accounting principles generally accepted in the United States of America. Such disclosures were included with the financial statements of the Company at February 28, 2019, and included in its report on Form 10-K. Such statements should be read in conjunction with the data herein.
The financial information reflects all adjustments, normal and recurring, which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The results for such interim periods are not necessarily indicative of the results to be expected for the year.
Inventories - Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress and the specific identification method for finished goods.
Land and Buildings – Land and buildings are stated at cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of forty years.
Long-Lived Assets - The Company periodically evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved.
Management Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
6
Marketable Securities - The Company has adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The fair value allowance of the securities at February 28, 2018 has been reclassified to Retained Earnings from Other Accumulated Comprehensive Income. The unrealized gain and loss on the marketable securities during the three months ended May 31, 2018 has been disclosed as a separate line item on the Income Statement.
New Accounting Pronouncements -
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either operating or financing, with such classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, and early adoption was permitted. The adoption of ASU 2016-02 had no material impact on the Company’s financial statements.
In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220), “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income”. ASU 2018-02 was issued to allow the reclassification from accumulated other comprehensive income to retained earnings for the stranded tax effect resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017. The Tax Cuts and Jobs Act, among other things, reduced the corporate tax rate from 35% to 21%, which required the re-evaluation of any deferred tax assets and liabilities at the lowered tax rate which potentially could leave a disproportionate tax effect in accumulated other comprehensive income. ASU 2018-02 allows for the election to reclassify these stranded tax effects to retained earnings. ASU 2018-02 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption was permitted, including adoption in any interim period for public business entities for reporting periods for which financials statements have not yet been issued. The adoption of ASU 2018-02 had no material impact on the Company’s financial statements.
Other than Accounting Standards Update (“ASU”) 2016-02 and ASU 2018-02 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.
Reclassifications – Where appropriate, certain reclassifications have been made to the prior period to conform to the presentations of the current period.
NOTE 3: REVENUE RECOGNITION
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. Under ASU 2014-09, revenue is recognized when a customer obtains control of promised goods or services and is recognized at an amount that reflects the consideration expected to be received in exchange for such goods or services. In addition, ASU 2014-09 requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The ASU is effective for fiscal years beginning after December 15, 2017.
The new revenue standard is principle based and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice, and guidance may evolve as companies and the accounting profession work to implement this new standard. The implementation of the standard did not have a material impact on the financial statements.
A majority of the Company’s sales revenue is derived primarily from short term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment transferred at a single point in time accounts for a majority of the Company’s revenue.
7
Sales revenue is recognized when control of the Company’s manufactured equipment is transferred to its customers, in an amount that reflects the consideration the Company expects to receive based upon the agreed transaction price. The Company’s performance obligations are satisfied when its customers take control of the purchased equipment, which is based on the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves. Sales are presented net of discounts and allowances. Discounts and allowances are determined when a sale is negotiated. The Company does not grant its customers or independent representatives, the ability to return equipment nor does it grant price adjustments after a sale is complete.
The Company does not capitalize any sales commission costs related to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed when the customer takes control of the purchased equipment.
At May 31, 2019, the Company had received $1,334,000 in cash deposits, and had issued Letters of Credit in the amount of $808,000 to secure these cash deposits. The Company was utilizing $808,000 of its available credit line to collateralize these letters of credit. The Company’s inventory included approximately $600,000 directly related to servicing these customer contracts.
NOTE 4: INVENTORIES
Inventories consist of the following:
May 31, | February 28, | |||||||
2019 | 2019 | |||||||
Raw materials and subassemblies | $ | 906,384 | $ | 873,483 | ||||
Finished goods | 511,267 | 571,640 | ||||||
Contracts in process inventory | 600,204 | — | ||||||
Work in process | 645,243 | 483,271 | ||||||
Total | 2,663,098 | 1,928,394 | ||||||
Less: Allowance | (284,378 | ) | (270,378 | ) | ||||
Net inventories | $ | 2,378,720 | $ | 1,658,016 |
NOTE 5: STOCK OPTIONS AND WARRANTS
Stock Options – Under the 2013 Stock Incentive Plan ("2013 Plan"), options can be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 2,500,000 shares of the Company's common stock. Under the 2013 Plan options expire ten years after the date of grant. As of May 31, 2019, there were 345,834 options outstanding under the 2013 Plan.
Under the 2003 Stock Incentive Plan, as amended ("2003 Plan"), until May 2013, options were available to be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 1,500,000 shares of the Company's common stock. As of May 31, 2019, there were 80,000 options outstanding under the 2003 Plan, under which no additional options may be granted.
During the three months ended May 31, 2019, 162,166 options were exercised on a cashless basis into 104,050 shares of common stock.
NOTE 6: STOCK BASED COMPENSATION
The Company adopted ASC 718, “Share Based Payments.” which requires companies to expense the value of employee stock options and similar awards.
The weighted-average fair value of options are estimated on the date of grant using the Black-Scholes options-pricing model. For the three months ended May 31, 2019 no options were issued.
8
In computing the impact, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period.
For the three months ended May 31, 2019 and 2018, net income and earnings per share reflect the actual deduction for stock-based compensation expense. The impact of applying ASC 718 approximated $11,000 and $9,000 in additional compensation expense during the three months ended May 31, 2019 and 2018, respectively. Such amounts are included in general and administrative expenses on the statement of operations. The expense for stock-based compensation is a non-cash expense item.
NOTE 7: EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
Three Months Ended May 31, | ||||||||
2019 | 2018 | |||||||
Numerator for basic and diluted earnings per share | $ | 25,213 | $ | 21,430 | ||||
Denominator for basic earnings per share - weighted average | 15,268,071 | 14,987,613 | ||||||
Effects of dilutive securities: | ||||||||
Stock options for employees, directors and outside consultants | 89,224 | 100,899 | ||||||
Denominator for diluted earnings per share | 15,357,295 | 15,088,512 | ||||||
Basic Earnings Per Share | $ | 0.00 | $ | 0.00 | ||||
Diluted Earnings Per Share | $ | 0.00 | $ | 0.00 |
NOTE 8: LONG TERM DEBT
Long-term debt consists of the following:
May 31, | February 28, | |||||||
2019 | 2019 | |||||||
Note payable, bank, collateralized by land and buildings, payable in monthly installments of principal and interest of $16,358 through January 2024. Interest rate 4.15%. 10-year term. | 830,248 | 870,531 | ||||||
Total long-term debt | 830,248 | 870,531 | ||||||
Due within one year | 164,410 | 162,816 | ||||||
Due after one year | $ | 665,838 | $ | 707,715 |
9
NOTE 9: REVOLVING LINE OF CREDIT
The Company has a $1,500,000 revolving line of credit at prime which was 5.50% at May 31, 2019. The revolving credit line is collateralized by the Company’s accounts receivable and inventory. The revolving credit line is payable on demand and must be retired for a 30-day period, once annually. If the Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert the outstanding balance to a 36-month term note with payments including interest in 36 equal installments.
As of May 31, 2019, $808,000 of the Company’s credit line was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on existing orders. The letters of credit expire in 2020. As of May 31, 2019, there were no outstanding borrowings under the line of credit and the unused portion of the credit line was $692,000 as of May 31, 2019.
NOTE 10: COMMITMENTS AND CONTINGENCIES
Other than the letters of credit disclosed in Note 8, the Company did not have any material commitments or contingencies as of May 31, 2019.
NOTE 11: SUBSEQUENT EVENTS
The Company has evaluated subsequent events for disclosure purposes.
10
ITEM 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, press releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive, technological and trade barrier developments affecting our operations or the demand for our products; timely development and market acceptance of new products; adequacy of financing; capacity additions; the ability to enforce patents; completion of backlog during the current fiscal year and the ability to achieve increased sales volume at projected levels and continued profitability.
We undertake no obligation to update any forward-looking statement.
Overview
Founded in 1975, Sono-Tek Corporation designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive. We also sell our products to emerging research and development and other markets. We have invested significant resources to enhance our market diversity by leveraging our core ultrasonic coating technology. As a result, we have increased our portfolio of products, the industries we serve and the countries in which we sell our products.
Our ultrasonic nozzle systems use high frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals. Our solutions are environmentally-friendly, efficient and highly reliable. They enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
We believe product superiority is imperative and that it is attained through the extensive experience we have in the coatings industry, our proprietary manufacturing know-how and skills and our unique work force we have built over the years. Our growth strategy is to leverage our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further advance the use of ultrasonic coating technologies for the microscopic coating of surfaces in a broader array of applications that enable better outcomes for our customers’ products and processes.
We are a global business with approximately 56% of our sales generated from outside the United States and Canada. Our direct sales team and our distributor and sales representative network is located in North America, Latin America, Europe and Asia. Over the last few years, we have expanded our sales capabilities by increasing the size of our direct sales force, adding new distributors and sales representatives (”reps”). In addition, we have established testing labs at our distribution partner sites in China, Taiwan, Germany, Turkey, Korea and Japan, while also expanding our first testing lab that is co-located with our manufacturing facilities in New York. These labs provide significant value for demonstrating to prospective customers the capabilities of our equipment and enabling us to develop custom solutions to meet their needs.
Over the last decade, we have shifted our business from primarily selling our ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems to original equipment manufacturers (“OEMs”). The range for our average unit selling price has increased as a result from less than $8,000 for a nozzle and generator package to a range of $50 thousand per unit to over $240 thousand per unit. As a result of this transition, we have broadened our addressable market and we believe that we can grow sales on a larger scale and we expect that we will experience wide variations in both order flow and shipments from quarter to quarter.
First Quarter Fiscal 2020 Highlights (compared with the first quarter of fiscal 2019 unless otherwise noted) We refer to the three-month periods ended May 31, 2019 and 2018 as the first quarter of fiscal 2020 and fiscal 2019, respectively.
· | Net sales were $2,822,000, up 4.5% or $121,000, driven primarily by demand from the Electronics/Microelectronics, Alternative Energy and Emerging R&D and Other industries markets. |
· | Gross profit margin decreased 1% due to product mix in the quarter. |
11
· | Net investment income comprised of interest and dividends and realized and unrealized gains and losses on marketable securities increased from $15,000 in fy2019 to $31,000 in fy2020. |
· | Backlog on May 31, 2019 grew 32% to $4,024,000, compared with backlog of $3,038,000 on February 28, 2019. |
Cash and cash equivalents and short-term investments at May 31, 2019 were $5,702,000, up from $5,510,000 at February 28, 2019. |
Total debt decreased $40,000 to $830,000 at May 31, 2019. |
Results of Operations
Sales:
Three Months Ended May 31, | Change | |||||||||||||||
2019 | 2018 | $ | % | |||||||||||||
Net Sales | $ | 2,822,000 | $ | 2,701,000 | $ | 121,000 | 4.5% | |||||||||
Cost of Goods Sold | 1,517,000 | 1,430,000 | 87,000 | 6% | ||||||||||||
Gross Profit | $ | 1,305,000 | $ | 1,271,000 | $ | 34,000 | 2.7% | |||||||||
Gross Profit % | 46.2% | 47.1% |
Product Sales:
Three Months Ended May 31, | Change | |||||||||||||||||||||||
2019 | % of total | 2018 | % of total | $ | % | |||||||||||||||||||
Fluxing Systems | $ | 391,000 | 14% | $ | 340,000 | 13% | 51,000 | 15% | ||||||||||||||||
Integrated Coating Systems | 396,000 | 14% | 349,000 | 13% | 47,000 | 13% | ||||||||||||||||||
Multi-Axis Coating Systems | 1,073,000 | 38% | 862,000 | 32% | 211,000 | 24% | ||||||||||||||||||
OEM Systems | 319,000 | 11% | 451,000 | 16% | (132,000 | ) | (29% | ) | ||||||||||||||||
Other | 643,000 | 23% | 699,000 | 26% | (56,000 | ) | (8% | ) | ||||||||||||||||
TOTAL | $ | 2,822,000 | $ | 2,701,000 | $ | 121,000 | 4% |
Sales growth was driven by demand for our more complex, highly-engineered and higher value multi-axis coating machines primarily for the Alternative Energy markets in in the first quarter of fiscal 2020. This equipment’s average selling price can range from $100 thousand to over $240 thousand per unit and is typically ordered in one-or two-unit volumes. Growth in these product categories more than offset the decline in integrated coating systems, which primarily are for more mature applications in the Medical market and can be highly variable in order volume.
Market Sales:
Three Months Ended May 31, | Change | |||||||||||||||||||||||
2019 | % of total | 2018 | % of total | $ | % | |||||||||||||||||||
Electronics/Microelectronics | $ | 1,538,000 | 55% | $ | 1,329,000 | 49% | 209,000 | 16% | ||||||||||||||||
Medical | 543,000 | 19% | 912,000 | 34% | (369,000 | ) | (40% | ) | ||||||||||||||||
Alternative Energy | 386,000 | 14% | 177,000 | 7% | 209,000 | 118% | ||||||||||||||||||
Emerging R&D and Other | 285,000 | 10% | 170,000 | 7% | 115,000 | 68% | ||||||||||||||||||
Industrial | 70,000 | 2% | 113,000 | 4% | (43,000 | ) | (38% | ) | ||||||||||||||||
TOTAL | $ | 2,822,000 | $ | 2,701,000 | $ | 121,000 | 4% |
12
Use of our application process development laboratory by customers reached record levels in FY2019, which we believe demonstrates the success of our strategy to provide excellent application engineering expertise as well as paid coating services to prospects and customers to validate the capabilities of our coating technologies for their uses. These service-based customers are guided by our applications engineering team, to develop successful coating processes for their unique needs. Upon achieving coating results that meet the application requirements, the customer's next step is typically to purchase the newly defined coating solution. We believe a high percentage of prospects and customers that use our lab services to develop their products results in sales of our ultrasonic coating solutions.
As expected, the Alternative Energy market continued to grow as applications and new requirements for fuel cell manufacturing equipment increased. Asia, specifically China, has been driving demand for fuel cells because of the investments being made by the Chinese government. Our equipment is used to produce highly durable, uniform, pinhole-free coatings of carbon-based catalyst inks onto fuel cell proton exchange membranes, reducing waste and improving functionality. Over the long term, demand from this market is poised for substantial growth as the industry continues to scale up from R&D prototype production to low rate production.
The industrial market showed a small decline in sales due to reduced orders in the float glass industry, which is typical due to variations in demand and applications from period to period. The decrease in the medical market was primarily influenced by a reduction in stent coating sales in China.
Geographic Sales:
Three Months Ended | ||||||||||||||||
May 31, | Change | |||||||||||||||
2019 | 2018 | $ | % | |||||||||||||
U.S. & Canada | $ | 1,229,000 | $ | 1,003,000 | $ | 226,000 | 23% | |||||||||
Asia Pacific (APAC) | 484,000 | 800,000 | (316,000 | ) | (40% | ) | ||||||||||
Europe, Middle East, Asia (EMEA) | 628,000 | 628,000 | — | — | ||||||||||||
Latin America | 481,000 | 270,000 | 211,000 | 78% | ||||||||||||
TOTAL | $ | 2,822,000 | $ | 2,701,000 | $ | 121,000 | 4% |
In the first quarter of fiscal 2020, approximately 56% of sales originated outside of the United States and Canada compared with 63% in the prior year period.
Gross Profit:
Our gross profit increased $34,000, or 2.7%, to $1,305,000 for the first quarter of fiscal 2020 compared with $1,271,000 in the prior year period. Our gross profit margin decreased 1% to 46.2% in the first quarter of fiscal 2020 compared to 47.1% in the prior year period. The decrease in gross profit margin during the quarter is primarily due to product mix.
Operating Expenses:
Three Months Ended | ||||||||||||||||
May 31, | Change | |||||||||||||||
2019 | 2018 | $ | % | |||||||||||||
Research and product development | $ | 337,000 | $ | 334,000 | $ | 3,000 | 1% | |||||||||
Marketing and selling | $ | 677,000 | $ | 630,000 | $ | 47,000 | 7% | |||||||||
General and administrative | $ | 286,000 | $ | 275,000 | $ | 11,000 | 4% | |||||||||
Total Operating Expenses | $ | 1,300,000 | $ | 1,239,000 | $ | 61,000 | 5% |
Research and Product Development:
Research and product development expense increased in the first quarter of fiscal 2020 due to increases in salaries and measurable increases in health insurance costs. These increases were partially offset by decreased engineering materials and supplies and travel expense.
13
Marketing and Selling:
Marketing and selling expenses increased in the first quarter of fiscal 2020 due to increases in sales salaries, measurable increases in health insurance costs and increased trade show expenses. These increases were partially offset by decreased travel expenses.
General and Administrative:
In the first quarter of fiscal 2020, we experienced increases in health insurance, corporate expenses and stock-based compensation expense.
Operating Income:
Operating income decreased to $5,000 in the first quarter of fiscal 2020 compared with $32,000 for the prior year period, a decrease of $27,000. The decrease in operating income is a result of our operating expenses increasing by $61,000 offset by an increase in our gross margin of $34,000, resulting in a net decrease of $27,000 in operating income. We continue to invest in our research and product development as well as marketing and selling activities in order to expand our future market opportunities. We expect with continued growth, we will begin to demonstrate operating leverage and improved margins.
Interest Expense:
Interest expense of $9,000 in the first fiscal quarter of 2020 compared with $11,000 for the prior year period.
Interest and Dividend Income:
Interest and dividend income decreased $3,000 to $31,000 in the first quarter of fiscal 2020 as compared with $35,000 for the first quarter of fiscal 2019. Our present investment policy is to invest excess cash in highly liquid, lower risk US Treasury securities. At May 31, 2019, the majority of our holdings are rated at or above investment grade.
Net unrealized loss on marketable securities:
The Company adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities” in the first quarter of fiscal 2019. ASU 2016-01 requires the Company to measure its equity investments at fair value and changes in fair value are to be recognized in net income. Further information is available in NOTE 2: SIGNIFICANT ACCOUNTING POLICIES in our financial statements.
In the first quarter of fiscal 2019, net income and earnings per share reflect the actual deduction of $49,000 for the unrealized loss on our marketable securities. For the first quarter of fiscal 2020 there was no unrealized gain or loss recorded for the Company’s marketable securities.
Other Income:
Included in other income is the net revenue related to the rental of the Company’s real estate. For the first quarter of fiscal 2020, the Company’s rental revenue was $20,000, expenses were $15,000 and the net profit was $5,000.
In the first quarter of fiscal 2019, the Company’s rental revenue was $18,000, expenses were $16,000 and the net profit was $2,000.
Income Tax Expense:
We recorded income tax expense of $6,000 for the first quarter of fiscal 2020 compared with $18,000 for the first quarter of fiscal 2019.
Net Income:
We had net income of $25,000 for the first quarter of fiscal 2020 compared with $21,000 for the prior year period for the reasons previously noted.
Fiscal Year 2020 Outlook
We expect that all of our backlog of $4,024,000 as of May 31, 2019 to ship during the fiscal year ending February 29, 2020, supporting our expectation that current fiscal year sales will grow in the range of 15% to 20%. Furthermore, we expect that this increased sales volume will expand margins and drive stronger earnings. Part of our anticipated growth is due to a $1,650,000 order for a newly introduced Robotic Coating Platform. This new platform will allow us to pursue additional prospects for six-axis robotic coating which presents an opportunity for ongoing growth.
14
Liquidity and Capital Resources
Working Capital – Our working capital decreased $46,000 to $6,378,000 at May 31, 2019 from $6,424,000 at February 28, 2019. The decrease in working capital was mostly the result of purchases of equipment and repayment of long-term debt partially offset by the current period's net income and noncash charges.
The Company aggregates cash and cash equivalents and marketable securities in managing its balance sheet and liquidity. For purposes of the following analysis, the total is referred to as “Cash.” At May 31, 2019 and February 28, 2019, our working capital included:
May 31, 2019 | February 28, 2019 | Cash Increase | ||||||||||
Cash and cash equivalents | $ | 1,923,000 | $ | 3,144,000 | ($ | 1,221,000 | ) | |||||
Marketable securities | 3,779,000 | 2,366,000 | 1,413,000 | |||||||||
Total | $ | 5,702,000 | $ | 5,510,000 | $ | 192,000 | ||||||
The following table summarizes the accounts and the major reasons for the $192,000 increase in “Cash”:
Impact on Cash | Reason | ||||
Accounts receivable decrease | $ | 66,000 | Cash receipts for accounts receivable | ||
Inventories increase | (735,000) | Required to support backlog. | |||
Prepaid expenses decrease | 290,000 | Previous deposits on inventory. | |||
Equipment purchases | (129,000) | Equipment upgrade. | |||
Customer deposits increase | 185,000 | Received for new orders. | |||
Accounts payable increase | 410,000 | Increase in inventory and timing of disbursements. | |||
Repayment of long-term debt | (40,000) | Repayment of debt. | |||
Other - net | 145,000 | Timing of disbursements. | |||
Net increase in cash | $ | 192,000 |
Stockholders’ Equity – Stockholder’s Equity increased $36,000 from $8,585,000 at February 28, 2019 to $8,621,000 at May 31, 2019. The increase is a result of the current period’s net income of $25,000 and stock-based compensation expense of $11,000.
Operating Activities – Our operating activities generated $362,000 of cash in the first quarter of fiscal 2020 compared with using $374,000 in the first quarter of fiscal 2019. The increase in cash generated by operating activities was mostly the result of increased accounts payable and customer deposits. These two sources of cash were partially offset by increased inventories and a decrease in prepaid expenses directly related to inventory. Our accounts payable increased $410,000 to $1,014,000 in the first quarter of fiscal 2020 compared to $586,000 at February 28, 2019. The increase is directly related to inventory purchases completed in the first quarter of fiscal 2020. The increase in inventory is a result of the Company’s increase in backlog.
Investing Activities – For the first quarter of fiscal 2020, we used $1,543,000 in our investing activities compared with using $62,000 for the first quarter of fiscal 2019. For the first quarters of fiscal years 2020 and 2019, we used $129,000 and $102,000, respectively, for the purchase or manufacture of equipment, furnishings and leasehold improvements. For the first quarter of fiscal 2020, we used $1,413,000 for the purchase of marketable securities and for the first quarter of 2019 our marketable securities provided $40,000.
Financing Activities – In the first quarter of fiscal years 2020 and 2019, we used $40,000 and $39,000, respectively, for the repayment of our notes payable.
Net (Decrease) in Cash – In the first quarter of fiscal 2020, our cash balance decreased by $1,221,000 as compared to a decrease of $475,000 in the first quarter of 2019. In the first quarter of fiscal 2020, our operating activities generated $362,000 of cash. In addition, we used $129,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements, used $1,413,000 for the purchase of marketable securities and $40,000 for the repayment of our note payable.
15
Critical Accounting Policies
The discussion and analysis of the Company’s financial condition and results of operations are based upon the consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure on contingent assets and liabilities at the date of the financial statements. Actual results may differ from these estimates under different assumptions and conditions.
Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties and may potentially result in materially different results under different assumptions and conditions. The Company believes that critical accounting policies are limited to those described below. For a detailed discussion on the application of these and other accounting policies see Note 2 to the Company’s consolidated financial statements included in Form 10-K for the year ended February 28, 2019.
Accounting for Income Taxes
As part of the process of preparing the Company’s condensed consolidated financial statements, the Company is required to estimate its income taxes. Management judgment is required in determining the provision for the deferred tax asset.
Stock-Based Compensation
The computation of the expense associated with stock-based compensation requires the use of a valuation model. ASC 718 is a complex accounting standard, the application of which requires significant judgment and the use of estimates, particularly surrounding Black-Scholes assumptions such as stock price volatility, expected option lives, and expected option forfeiture rates, to value equity-based compensation. The Company currently uses a Black-Scholes option pricing model to calculate the fair value of its stock options. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes model and has no reason to believe that future data is likely to differ materially from historical data. However, changes in the assumptions to reflect future stock price volatility and future stock award exercise experience could result in a change in the assumptions used to value awards in the future and may result in a material change to the fair value calculation of stock-based awards. ASC 718 requires the recognition of the fair value of stock compensation in net income. Although every effort is made to ensure the accuracy of our estimates and assumptions, significant unanticipated changes in those estimates, interpretations and assumptions may result in recording stock option expense that may materially impact our financial statements for each respective reporting period.
Impact of New Accounting Pronouncements
Accounting pronouncements issued but not yet effective have been deemed to be not applicable or the adoption of such accounting pronouncements are not expected to have a material impact on the financial statements of the Company.
ITEM 3 - Quantitative and Qualitative Disclosures about Market Risk
The Company does not issue or invest in financial instruments or derivatives for trading or speculative purposes. Substantially all of the operations of the Company are conducted in the United States, and, as such, are not subject to material foreign currency exchange rate risk. All of our sales transactions are completed in US dollars.
Although the Company's assets included $1,923,000 in cash and $3,779,000 in marketable securities, the market rate risk associated with changing interest rates in the United States is not material.
16
ITEM 4 – Controls and Procedures
The Company has established and maintains “disclosure controls and procedures” (as those terms are defined in Rules 13a –15(e) and 15d-15(e) under the Securities and Exchange Act of 1934 (the “Exchange Act”). Christopher L. Coccio, Chief Executive Officer (principal executive) and Stephen J. Bagley, Chief Financial Officer (principal accounting officer) of the Company, have evaluated the Company’s disclosure controls and procedures as of May 31, 2019. Based on this evaluation, they have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding timely disclosure.
In addition, there were no changes in the Company’s internal controls over financial reporting during the first fiscal quarter of 2020 that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.
PART II - OTHER INFORMATION
Item 1. | Legal Proceedings | |
None | ||
Item 1A. | Risk Factors | |
Note Required for Smaller Reporting Companies | ||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. | |
None | ||
Item 3. | Defaults Upon Senior Securities | |
None | ||
Item 4. | Mine Safety Disclosures | |
None | ||
Item 5. | Other Information | |
None | ||
Item 6. | Exhibits and Reports | |
31.1– 31.2 – Rule 13a - 14(a)/15d – 14(a) Certification | ||
32.1 – 32.2 – Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS – XBRL Instance Document. | ||
101.SCH – XBRL Taxonomy Extension Schema Document | ||
101.CAL – XBRL Taxonomy Calculation Linkbase Document | ||
101.DEF – XBRL Taxonomy Extension Definition Linkbase Document | ||
101.LAB – XBRL Extension Label Linkbase Document | ||
101.PRE – XBRL Taxonomy Extension Presentation Linkbase Document |
17
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: July 15, 2019
SONO-TEK CORPORATION | ||
(Registrant) | ||
By: | /s/ Christopher L. Coccio | |
Christopher L. Coccio | ||
Chief Executive Officer | ||
By: | /s/ Stephen J. Bagley | |
Stephen J. Bagley | ||
Chief Financial Officer |
18